Is muscle loss a known side effect of GLP-1 drugs?

Reviewed by Yoshinori Abe, MD

Internal Medicine

GLP-1 medications, such as Ozempic and Wegovy, are commonly prescribed for type 2 diabetes and weight loss. However, one important side effect to be aware of is muscle loss. Studies show that a significant portion of weight lost while taking GLP-1 drugs can come from lean muscle mass rather than fat, which may impact strength, metabolism, and long-term health.

If you're taking a GLP-1 medication and noticing changes in your body, energy levels, or overall well-being, it's worth investigating further. Muscle loss can have lasting effects, so understanding your symptoms early is key. Take a free, instant, online symptom check to better understand what's happening and identify the best next steps for your health.

Reviewed for medical accuracy: 07/20/2026

Important Next Steps

Learn if GLP-1 muscle loss is serious Discover likely causes of muscle loss See if your muscle loss needs care Find OTC options for muscle loss relief Find doctors for muscle loss treatment Discover home remedies for muscle loss Find out if muscle loss needs evaluation

Not seeing your question? No worries.

Submit your own Question

Explanation

GLP-1 drugs, often used for weight management and diabetes, have been studied for their effects on muscle mass. Research indicates that these medications can lead to a reduction in lean body mass, which includes muscle.

Studies have discussed these changes, suggesting a decrease in muscle mass over time. Research also highlights that GLP-1 receptor agonists can affect muscle, potentially leading to muscle loss, which is important for patients to be aware of. Further investigations into the relationship between GLP-1 drugs and muscle mass support the idea that muscle loss can occur.

Understanding these effects is important for individuals taking GLP-1 drugs, as maintaining muscle mass is crucial for overall health. If you're experiencing unusual symptoms or concerns about muscle loss, you can use Ubie's free AI-powered symptom checker to help identify what might be happening, and then discuss your results with your healthcare provider.

(References)

Neeland IJ, Linge J, & Birkenfeld AL. (2024). Changes in lean body mass with glucagon-like peptide-1- .... Diabetes, obesity & metabolism, 38937282.
Old VJ, Davies MJ, Papamargaritis D, Choudhary P, & Watson EL. (2025). The Effects of Glucagon-Like Peptide-1 Receptor Agonists .... Journal of cachexia, sarcopenia and muscle, 39815782.
Linge J, Birkenfeld AL, & Neeland IJ. (2024). Muscle Mass and Glucagon-Like Peptide-1 Receptor .... Circulation, 39401279.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.